Creative Planning Exelixis, Inc. Transaction History

Creative Planning

$90.1 Billion
Q1 2024

A detailed history of Creative Planning transactions in Exelixis, Inc. stock. As of the latest transaction made, Creative Planning holds 71,152 shares of EXEL stock, worth $1.58 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

71,152

Previous 82,489 13.74%

Holding current value

$1.58 Million

Previous $1.98 Million 14.66%

% of portfolio

0.0%

Previous 0.0%

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 10, 2024	SELL	$20.17 - $23.93 $228,667 - $271,294	-11,337 Reduced 13.74%	71,152 $1.69 Million
Q4 2023 Feb 14, 2024	BUY	$19.25 - $24.13 $94,575 - $118,550	4,913 Added 6.33%	82,489 $1.98 Million
Q3 2023 Nov 16, 2023	SELL	$19.04 - $22.74 $166,333 - $198,656	-8,736 Reduced 10.12%	77,576 $1.7 Million
Q2 2023 Jul 21, 2023	SELL	$18.17 - $20.48 $189,313 - $213,381	-10,419 Reduced 10.77%	86,312 $1.65 Million
Q1 2023 May 15, 2023	BUY	$16.3 - $19.41 $351,525 - $418,596	21,566 Added 28.69%	96,731 $1.88 Million

Q4 2022 Feb 10, 2023	SELL	$14.96 - $17.39 $7,749 - $9,008	-518 Reduced 0.68%	75,165 $1.21 Million
Q3 2022 Nov 03, 2022	BUY	$15.68 - $22.27 $7,134 - $10,132	455 Added 0.6%	75,683 $1.19 Million
Q2 2022 Aug 15, 2022	SELL	$17.44 - $23.16 $16,585 - $22,025	-951 Reduced 1.25%	75,228 $1.57 Million
Q1 2022 May 16, 2022	SELL	$17.03 - $22.67 $27,213 - $36,226	-1,598 Reduced 2.05%	76,179 $1.73 Million
Q4 2021 Feb 11, 2022	SELL	$15.84 - $21.88 $81,211 - $112,178	-5,127 Reduced 6.18%	77,777 $1.42 Million
Q3 2021 Nov 10, 2021	SELL	$16.3 - $21.14 $30,513 - $39,574	-1,872 Reduced 2.21%	82,904 $1.75 Million
Q2 2021 Aug 04, 2021	SELL	$17.95 - $25.56 $488,742 - $695,947	-27,228 Reduced 24.31%	84,776 $1.55 Million
Q1 2021 Apr 30, 2021	SELL	$20.53 - $25.22 $146,892 - $180,449	-7,155 Reduced 6.0%	112,004 $2.53 Million
Q4 2020 Jan 29, 2021	BUY	$18.39 - $24.8 $705,734 - $951,724	38,376 Added 47.51%	119,159 $2.39 Million
Q3 2020 Nov 05, 2020	SELL	$20.67 - $26.94 $28,069 - $36,584	-1,358 Reduced 1.65%	80,783 $1.98 Million
Q2 2020 Jul 23, 2020	BUY	$16.46 - $27.42 $168,550 - $280,780	10,240 Added 14.24%	82,141 $1.95 Million
Q1 2020 May 05, 2020	BUY	$14.46 - $21.8 $8,083 - $12,186	559 Added 0.78%	71,901 $1.24 Million
Q4 2019 Jan 30, 2020	SELL	$15.15 - $18.89 $2.29 Million - $2.85 Million	-151,094 Reduced 67.93%	71,342 $1.26 Million
Q3 2019 Nov 01, 2019	SELL	$17.68 - $22.65 $188,645 - $241,675	-10,670 Reduced 4.58%	222,436 $3.93 Million
Q2 2019 Jul 26, 2019	BUY	$18.93 - $24.75 $686,477 - $897,534	36,264 Added 18.42%	233,106 $4.98 Million
Q1 2019 Apr 24, 2019	SELL	$19.6 - $24.76 $1.04 Million - $1.32 Million	-53,259 Reduced 21.29%	196,842 $4.69 Million
Q4 2018 Feb 01, 2019	SELL	$13.65 - $21.8 $627,859 - $1 Million	-45,997 Reduced 15.53%	250,101 $4.92 Million
Q3 2018 Oct 25, 2018	BUY	$15.87 - $22.4 $3.11 Million - $4.4 Million	196,217 Added 196.45%	296,098 $5.25 Million
Q2 2018 Jul 20, 2018	SELL	$18.56 - $22.45 $267,969 - $324,133	-14,438 Reduced 12.63%	99,881 $2.15 Million
Q1 2018 Apr 18, 2018	BUY	$22.15 - $31.89 $133,387 - $192,041	6,022 Added 5.56%	114,319 $2.53 Million
Q4 2017 Jan 17, 2018	BUY	$24.23 - $30.93 $385,499 - $492,096	15,910 Added 17.22%	108,297 $3.29 Million
Q3 2017 Oct 17, 2017	BUY	$23.35 - $29.24 $2.16 Million - $2.7 Million	92,387	92,387 $2.24 Million

Others Institutions Holding EXEL

# of Institutions

460

Shares Held

246M

Call Options Held

1.7M

Put Options Held

1.02M

View Full List

About EXELIXIS, INC.

Ticker EXEL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 321,832,000
Market Cap $7.13B
Description
Exelixis, Inc., an oncology-focused biotechnology company, focuses on the discovery, development, and commercialization of new medicines to treat cancers in the United States. The company's products include CABOMETYX tablets for the treatment of patients with advanced renal cell carcinoma who received prior anti-angiogenic therapy; and COMETRIQ ...

More about EXEL

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Creative Planning, based on Form 13F filings with the SEC.

News

Stay updated on Creative Planning with notifications on news.

Account

Creative Planning Exelixis, Inc. Transaction History